179 related articles for article (PubMed ID: 10529440)
1. GDNF partially protects grafted fetal dopaminergic neurons against 6-hydroxydopamine neurotoxicity.
Yurek DM; Fletcher-Turner A
Brain Res; 1999 Oct; 845(1):21-7. PubMed ID: 10529440
[TBL] [Abstract][Full Text] [Related]
2. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
Yurek DM
Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
[TBL] [Abstract][Full Text] [Related]
3. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats.
Wang Y; Tien LT; Lapchak PA; Hoffer BJ
Cell Tissue Res; 1996 Nov; 286(2):225-33. PubMed ID: 8854891
[TBL] [Abstract][Full Text] [Related]
4. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
Aoi M; Date I; Tomita S; Ohmoto T
Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110
[TBL] [Abstract][Full Text] [Related]
5. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
6. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
[TBL] [Abstract][Full Text] [Related]
7. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum.
Granholm AC; Mott JL; Bowenkamp K; Eken S; Henry S; Hoffer BJ; Lapchak PA; Palmer MR; van Horne C; Gerhardt GA
Exp Brain Res; 1997 Aug; 116(1):29-38. PubMed ID: 9305812
[TBL] [Abstract][Full Text] [Related]
8. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells.
Apostolides C; Sanford E; Hong M; Mendez I
Neuroscience; 1998 Mar; 83(2):363-72. PubMed ID: 9460746
[TBL] [Abstract][Full Text] [Related]
9. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.
Kirik D; Rosenblad C; Björklund A
Eur J Neurosci; 2000 Nov; 12(11):3871-82. PubMed ID: 11069582
[TBL] [Abstract][Full Text] [Related]
10. GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamine.
Cass WA; Manning MW
J Neurosci; 1999 Feb; 19(4):1416-23. PubMed ID: 9952418
[TBL] [Abstract][Full Text] [Related]
11. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
Espejo M; Cutillas B; Arenas TE; Ambrosio S
Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
[TBL] [Abstract][Full Text] [Related]
12. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.
Kearns CM; Gash DM
Brain Res; 1995 Feb; 672(1-2):104-11. PubMed ID: 7749731
[TBL] [Abstract][Full Text] [Related]
13. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.
Sullivan AM; Opacka-Juffry J; Blunt SB
Eur J Neurosci; 1998 Jan; 10(1):57-63. PubMed ID: 9753113
[TBL] [Abstract][Full Text] [Related]
14. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
[TBL] [Abstract][Full Text] [Related]
16. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of GDNF against 6-OHDA in young and aged rats.
Fox CM; Gash DM; Smoot MK; Cass WA
Brain Res; 2001 Mar; 896(1-2):56-63. PubMed ID: 11277973
[TBL] [Abstract][Full Text] [Related]
18. Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro.
Eggert K; Schlegel J; Oertel W; Würz C; Krieg JC; Vedder H
Neurosci Lett; 1999 Jul; 269(3):178-82. PubMed ID: 10454161
[TBL] [Abstract][Full Text] [Related]
19. Comparison of mesencephalic free-floating tissue culture grafts and cell suspension grafts in the 6-hydroxydopamine-lesioned rat.
Meyer M; Widmer HR; Wagner B; Guzman R; Evtouchenko L; Seiler RW; Spenger C
Exp Brain Res; 1998 Apr; 119(3):345-55. PubMed ID: 9551835
[TBL] [Abstract][Full Text] [Related]
20. Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.
Cass WA; Peters LE
Neurochem Int; 2010 Nov; 57(5):540-6. PubMed ID: 20615442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
